Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
$4.95M Sell
25,441
-1,009
-4% -$197K 2.65% 5
2018
Q3
$5.48M Sell
26,450
-549
-2% -$108K 2.5% 4
2018
Q2
$4.98M Sell
26,999
-200
-0.7% -$35.4K 2.36% 4
2018
Q1
$4.64M Sell
27,199
-79
-0.3% -$14.5K 2.2% 6
2017
Q4
$4.74M Sell
27,278
-490
-2% -$86.7K 2.2% 6
2017
Q3
$5.18M Buy
27,768
+1
+0% +$177 2.4% 4
2017
Q2
$4.78M Hold
27,767
2.26% 7
2017
Q1
$4.56M Buy
27,767
+26
+0.1% +$4.32K 2.12% 9
2016
Q4
$4.06M Hold
27,741
1.93% 12
2016
Q3
$4.63M Buy
27,741
+1
+0% +$169 2.25% 7
2016
Q2
$4.22M Sell
27,740
-790
-3% -$123K 2.06% 9
2016
Q1
$4.28M Sell
28,530
-374
-1% -$55.6K 2.2% 7
2015
Q4
$4.69M Sell
28,904
-2,400
-8% -$377K 2.45% 6
2015
Q3
$4.33M Sell
31,304
-164
-0.5% -$25.9K 2.32% 6
2015
Q2
$4.83M Sell
31,468
-1,275
-4% -$204K 2.43% 6
2015
Q1
$5.23M Sell
32,743
-2,534
-7% -$399K 2.48% 5
2014
Q4
$5.62M Sell
35,277
-199
-0.6% -$31K 2.65% 3
2014
Q3
$4.98M Sell
35,476
-700
-2% -$91.4K 2.47% 5
2014
Q2
$4.28M Sell
36,176
-79
-0.2% -$9.14K 2.06% 12
2014
Q1
$4.47M Sell
36,255
-49
-0.1% -$5.94K 2.26% 9
2013
Q4
$4.14M Sell
36,304
-2,100
-5% -$239K 2.19% 10
2013
Q3
$4.3M Buy
38,404
+100
+0.3% +$10.8K 2.47% 6
2013
Q2
$3.78M Buy
+38,304
New +$3.97M 2.25% 9

Other funds holding AMGN

Marshwinds Advisory's AMGN Position: Q4 2018 in Review

Marshwinds Advisory reduced its Amgen (AMGN) stake by 3.8% in Q4 2018, selling an estimated $197K and leaving 25,441 shares worth $4.95M. The position accounts for 2.65% of the portfolio, ranked #5.

Marshwinds Advisory first reported a position in AMGN in Q2 2013 and has held it in 23 quarters since. The position peaked at $5.62M in Q4 2014. 1,892 funds tracked by Wall St. Rank hold AMGN as of Q4 2018.

  • Marshwinds Advisory held 25,441 shares of Amgen worth $4.95M as of Q4 2018.
  • Marshwinds Advisory sold 1,009 Amgen shares in Q4 2018, an estimated $197K.
  • Amgen made up 2.65% of Marshwinds Advisory's portfolio in Q4 2018, its #5 holding.
  • Marshwinds Advisory first reported a position in Amgen in Q2 2013 and has held it in 23 quarters since.
  • Marshwinds Advisory's Amgen position peaked at $5.62M in Q4 2014.
  • 1,892 funds tracked by Wall St. Rank held Amgen as of Q4 2018.

Based on Marshwinds Advisory's 13F filing for Q4 2018, filed 7 Jan 2019.